ProfileGDS4718 / 230464_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 42% 36% 40% 35% 33% 36% 39% 39% 34% 31% 38% 37% 33% 37% 36% 32% 39% 32% 46% 38% 38% 37% 34% 39% 30% 30% 30% 35% 30% 31% 37% 41% 39% 33% 32% 31% 36% 35% 35% 40% 36% 40% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8182936
GSM549102patient 115, normal, homogenized [OPG study]5.094642
GSM549104patient 119, normal, homogenized [OPG study]4.7890336
GSM549108patient 138, normal, homogenized [OPG study]5.0317140
GSM549119patient 077, normal, homogenized [OPG study]4.7853335
GSM549133patient 032, cancer, homogenized [OPG study]4.6182133
GSM549139patient 042, cancer, homogenized [OPG study]4.7776536
GSM549099patient 107, normal, homogenized [OPG study]4.9676539
GSM549109patient 139, normal, homogenized [OPG study]4.9822439
GSM549110patient 046, normal, homogenized [OPG study]4.7239234
GSM549114patient 063, normal, homogenized [OPG study]4.5594231
GSM549122patient 082, normal, homogenized [OPG study]4.9165438
GSM549134patient 033, cancer, homogenized [OPG study]4.8500837
GSM549136patient 036, cancer, homogenized [OPG study]4.6030633
GSM549140patient 044, cancer, homogenized [OPG study]4.8214437
GSM549111patient 047, normal, homogenized [OPG study]4.7608636
GSM549113patient 057, normal, homogenized [OPG study]4.5831232
GSM549132patient 031, cancer, homogenized [OPG study]4.9318439
GSM549137patient 038, cancer, homogenized [OPG study]4.6003232
GSM549142patient 047, cancer, homogenized [OPG study]5.4187746
GSM549100patient 110, normal, homogenized [OPG study]4.9368738
GSM549107patient 135, normal, homogenized [OPG study]4.8795138
GSM549115patient 068, normal, homogenized [OPG study]4.7944637
GSM549116patient 072, normal, homogenized [OPG study]4.6693234
GSM549120patient 078, normal, homogenized [OPG study]4.9318939
GSM549131patient 030, cancer, homogenized [OPG study]4.472230
GSM549118patient 074, normal, homogenized [OPG study]4.550230
GSM549129patient 027, cancer, homogenized [OPG study]4.5687230
GSM549123patient 088, normal, homogenized [OPG study]4.7384235
GSM549124patient 006, cancer, homogenized [OPG study]4.5837730
GSM549126patient 015, cancer, homogenized [OPG study]4.5731331
GSM549128patient 025, cancer, homogenized [OPG study]4.8258537
GSM549103patient 117, normal, homogenized [OPG study]5.1262441
GSM549117patient 073, normal, homogenized [OPG study]4.8944839
GSM549138patient 041, cancer, homogenized [OPG study]4.6513433
GSM549141patient 045, cancer, homogenized [OPG study]4.5730732
GSM549130patient 028, cancer, homogenized [OPG study]4.598631
GSM549101patient 111, normal, homogenized [OPG study]4.8140636
GSM549105patient 128, normal, homogenized [OPG study]4.8049235
GSM549106patient 134, normal, homogenized [OPG study]4.7238235
GSM549112patient 048, normal, homogenized [OPG study]4.9952640
GSM549125patient 011, cancer, homogenized [OPG study]4.8083736
GSM549127patient 024, cancer, homogenized [OPG study]4.9840140
GSM549135patient 035, cancer, homogenized [OPG study]4.6712734